MedinCell S.A. (EPA:MEDCL)

France · Delayed Price · Currency is EUR

22.20

-0.98 (-4.23%)

Oct 2, 2026, 5:35 PM CET

MedinCell Employees

MedinCell had 141 employees as of March 31, 2026. The number of employees increased by 10 or 7.63% compared to the previous year.

Employees

141

Change

10

Growth

7.63%

Revenue / Employee

€172,177

Profits / Employee

€221,894

Market Cap

797.24M

Employees Chart

Employees History

Date	Employees	Change (1Y)	Growth (1Y)
Mar 31, 2026	141	10	7.63%
Mar 31, 2025	131	-3	-2.24%
Mar 31, 2024	134	3	2.29%
Mar 31, 2023	131	-8	-5.76%
Mar 31, 2022	139	1	0.72%
Mar 31, 2021	Upgrade Pro	Upgrade Pro	Upgrade Pro
Mar 31, 2020	Upgrade Pro	Upgrade Pro	Upgrade Pro
Mar 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Mar 31, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro
Mar 31, 2017	Upgrade Pro	Upgrade Pro	Upgrade Pro

Related Stocks

Company Name	Employees
Valneva SE	620
Cellectis	229
DBV Technologies	170
Genfit	161
Transgene	145
Innate Pharma	120
Nanobiotix	100
ABIVAX Société Anonyme	98

Employee Rankings

MedinCell News

9 days ago - MedinCell initiated with an Outperform at Oppenheimer - TheFly
11 days ago - Medincell's Partner Teva Presented New Data on Investigational Olanzapine LAI and UZEDY® at Psych Congress 2026 - Business Wire
23 days ago - Medincell to Participate in Upcoming Investor Conferences - Business Wire
24 days ago - Medincell: Publication of the Notice of Meeting and Reminder of the Participation terms in the Combined General Meeting - Business Wire
4 weeks ago - Medincell Appoints Edna Venneker As CMO To Advance Long-Acting Drug Portfolio - Nasdaq
4 weeks ago - Medincell Appoints Edna Venneker, MD, as Chief Medical Officer - Business Wire
7 weeks ago - Medincell's Dr Grace Kim to Participate in Piper Sandler CNS Symposium - Business Wire
2 months ago - Medincell: UZEDY®: Record Q2 Net Sales of $77M, Up 43% YoY; Teva Raises 2026 Outlook - Business Wire